Stock BLRX BIOLINERX LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart BioLineRx Ltd.

Equities

BLRX

IL0011015182

Market Closed - TEL AVIV STOCK EXCHANGE
Other stock markets
 10:24:55 2024-07-03 EDT 		5-day change 1st Jan Change
14.8 ILa -1.33% Intraday chart for BioLineRx Ltd. -9.76% -61.26%
05-30 BioLineRx Ltd Announces Clinical Trial Agreement with St. Jude Children's Research Hospital, Inc. to Evaluate Motixafortide for CD34+ Hematopoietic Stem Cell Mobilization For Gene Therapy Applications in Sickle Cell Disease CI
05-28 Transcript : BioLineRx Ltd., Q1 2024 Earnings Call, May 28, 2024
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
BIOLINERX LTD. Stock BioLineRx Ltd.
 47.7M - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 122B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 113B
ARGENX SE Stock argenx SE
 26.22B -
BIONTECH SE Stock BioNTech SE
 19.01B -
GENMAB A/S Stock Genmab A/S
 15.71B
  1. Stock Market
  2. Equities
  3. BLRX Stock
  4. Charts BioLineRx Ltd.
  5. Sector Chart